BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32980885)

  • 1. Deciphering the role of Wnt signaling in acute myeloid leukemia prognosis: how alterations in DNA methylation come into play in patients' prognosis.
    Cardona-Echeverry A; Prada-Arismendy J
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3097-3109. PubMed ID: 32980885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated approach of gene expression and DNA-methylation profiles of WNT signaling genes uncovers novel prognostic markers in acute myeloid leukemia.
    Taskesen E; Staal FJ; Reinders MJ
    BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S4. PubMed ID: 25734857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DIXDC1 promotes the growth of acute myeloid leukemia cells by upregulating the Wnt/β-catenin signaling pathway.
    Xin H; Li C; Wang M
    Biomed Pharmacother; 2018 Nov; 107():1548-1555. PubMed ID: 30257373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells.
    Morgan RG; Ridsdale J; Payne M; Heesom KJ; Wilson MC; Davidson A; Greenhough A; Davies S; Williams AC; Blair A; Waterman ML; Tonks A; Darley RL
    Haematologica; 2019 Jul; 104(7):1365-1377. PubMed ID: 30630973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.
    Müller-Tidow C; Steffen B; Cauvet T; Tickenbrock L; Ji P; Diederichs S; Sargin B; Köhler G; Stelljes M; Puccetti E; Ruthardt M; deVos S; Hiebert SW; Koeffler HP; Berdel WE; Serve H
    Mol Cell Biol; 2004 Apr; 24(7):2890-904. PubMed ID: 15024077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia.
    Cheng CK; Li L; Cheng SH; Ng K; Chan NP; Ip RK; Wong RS; Shing MM; Li CK; Ng MH
    Blood; 2011 Dec; 118(25):6638-48. PubMed ID: 22031861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.
    Kühnl A; Valk PJ; Sanders MA; Ivey A; Hills RK; Mills KI; Gale RE; Kaiser MF; Dillon R; Joannides M; Gilkes A; Haferlach T; Schnittger S; Duprez E; Linch DC; Delwel R; Löwenberg B; Baldus CD; Solomon E; Burnett AK; Grimwade D
    Blood; 2015 May; 125(19):2985-94. PubMed ID: 25805812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
    Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
    Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-canonical activation of β-catenin by PRL-3 phosphatase in acute myeloid leukemia.
    Chong PSY; Zhou J; Chooi JY; Chan ZL; Toh SHM; Tan TZ; Wee S; Gunaratne J; Zeng Q; Chng WJ
    Oncogene; 2019 Feb; 38(9):1508-1519. PubMed ID: 30305722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.
    Valencia A; Román-Gómez J; Cervera J; Such E; Barragán E; Bolufer P; Moscardó F; Sanz GF; Sanz MA
    Leukemia; 2009 Sep; 23(9):1658-66. PubMed ID: 19387464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regeneration-associated WNT signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells.
    Beghini A; Corlazzoli F; Del Giacco L; Re M; Lazzaroni F; Brioschi M; Valentini G; Ferrazzi F; Ghilardi A; Righi M; Turrini M; Mignardi M; Cesana C; Bronte V; Nilsson M; Morra E; Cairoli R
    Neoplasia; 2012 Dec; 14(12):1236-48. PubMed ID: 23308055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
    He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia.
    Martín V; Valencia A; Agirre X; Cervera J; San Jose-Eneriz E; Vilas-Zornoza A; Rodriguez-Otero P; Sanz MA; Herrera C; Torres A; Prosper F; Román-Gómez J
    Cancer Sci; 2010 Feb; 101(2):425-32. PubMed ID: 19874313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
    Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
    Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
    [No Abstract]   [Full Text] [Related]  

  • 16. Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression.
    Yao QM; Li PP; Liang SM; Lu K; Zhu XJ; Liu YX; Zhang F; Yuan T; Wang X
    Int J Clin Exp Pathol; 2015; 8(7):7921-8. PubMed ID: 26339357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis.
    Petropoulos K; Arseni N; Schessl C; Stadler CR; Rawat VP; Deshpande AJ; Heilmeier B; Hiddemann W; Quintanilla-Martinez L; Bohlander SK; Feuring-Buske M; Buske C
    J Exp Med; 2008 Mar; 205(3):515-22. PubMed ID: 18316418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis.
    Feder K; Edmaier-Schröger K; Rawat VPS; Kirsten N; Metzeler K; Kraus JM; Döhner K; Döhner H; Kestler HA; Feuring-Buske M; Buske C
    Leukemia; 2020 Apr; 34(4):1027-1037. PubMed ID: 31758089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of lymphoid enhancer-binding factor 1 expression in acute myeloid leukemia.
    Fu Y; Zhu H; Wu W; Xu J; Chen T; Xu B; Qian S; Li J; Liu P
    Leuk Lymphoma; 2014 Feb; 55(2):371-7. PubMed ID: 23713453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association.
    Gebhard C; Glatz D; Schwarzfischer L; Wimmer J; Stasik S; Nuetzel M; Heudobler D; Andreesen R; Ehninger G; Thiede C; Rehli M
    Leukemia; 2019 Jan; 33(1):26-36. PubMed ID: 29925905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.